TrialSignal
Clinical trial intelligence report
Efficacy of Antidepressants in Chronic Back Pain
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 13, 2026
NCT ID
NCT00018200
Status
COMPLETED
Phase
PHASE2
Sponsor
US Department of Veterans Affairs
Executive brief
Investment-Ready Snapshot
The purpose of this study is to determine whether different types of antidepressant medicines relieve back pain that has lasted at least six months on a daily basis. Study participants will be assigned to treatment with either a antidepressant acting on the serotonin system in the brain (fluoxetine), one acting on the noradrenaline system (desipramine, or to a control medication not expected to relieve pain (benztropine). Each participant will be seen at least nine times during their 12 weeks on medication. This is a phase 2/3, outpatient study.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT00018200
Indication
Back Pain
Modality
small molecule
Target
Desipramine, Fluoxetine, Benztropine
Intervention
Desipramine, Fluoxetine, Benztropine
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.